What are the relevant domestic laws and policies for IVF?
In recent years, with the continuous development of medical technology and the increase of social demand, the IVF technology has been widely used in China. In order to standardize the medical practice of IVF and protect the legitimate rights and interests of infants and families, China has formulated a series of relevant laws and policies. This article will elaborate on relevant domestic laws and policies from four aspects.
Management of IVF medical institutions
The National Health Commission of China issued the Administrative Measures for Human Assisted Reproduction Technology in 2001, which clearly stipulates that IVF medical institutions must obtain relevant qualifications to carry out the practice of this technology. These institutions need to have certain medical equipment and qualified medical teams to ensure the safety and effectiveness of technical operations. In addition, medical institutions also need to comply with relevant ethical norms, such as protecting the privacy and confidentiality of patients, and regularly accept the inspection and assessment of the competent business department.
In terms of management license, China has also formulated corresponding regulations. According to the Administrative Measures for the Practicing License of Medical Institutions, IVF medical institutions need to obtain a practicing license before they can legally carry out relevant medical services. This measure aims to strengthen the management and supervision of medical institutions and ensure the compliant operation of IVF technology.
Norms of Fertility for IVF
China's Law on the Protection of Women's Rights and Interests and the Measures for the Administration of Human Assisted Reproductive Technology both regulate the reproductive behavior of IVF. These regulations clearly stipulate that couples participating in IVF technology must be legally married and have full civil capacity to bear. In addition, the birth process of infants should be based on the principles of voluntariness, knowledge and truthfulness. Medical institutions cannot force or guide couples to choose IVF technology in any form.
In addition, China has also formulated corresponding moral standards and ethical guidelines for the social and ethical issues of IVF technology. For example, IVF medical institutions prohibit sex selection, excessive egg retrieval and IVF surrogacy to protect the rights and interests of infants and families.
Protection of rights and interests of test tube babies
In the laws and policies related to IVF, protecting the rights and interests of infants is an important aspect. The Measures for the Administration of Human Assisted Reproduction Technology clearly stipulates that medical institutions should ensure the safety of infants in the process of embryo transfer, pregnancy and birth. At the same time, genetic testing and genetic counseling for infants should also comply with ethical norms. These provisions not only protect the health and personal safety of infants, but also protect their rights and interests in the origin of life and individual development.
Supervision and accountability of IVF
In order to ensure the scientific and compliant application of IVF medical technology, China has also established a corresponding supervision and accountability mechanism. Health administrative departments at all levels are responsible for the supervision and management of IVF medical institutions, and the investigation, punishment and handling of illegal acts. When a medical institution violates the law or fails to perform its corresponding obligations, it will face administrative punishment or accountability.
In general, the laws and policies related to IVF in China mainly include the management of medical institutions, reproductive norms, protection of infant rights and interests, supervision and accountability. The formulation and implementation of these policies not only effectively regulate the application of IVF technology, but also protect the legitimate rights and interests of relevant participants and the personal safety of infants. With the continuous development of society and technological progress, I believe that the relevant laws and policies will continue to be improved and optimized to provide better protection for the healthy development of IVF technology.
